PP07 Presentation Time: 11:00 AM

Chad Tang,Jeremiah Sanders,Howard Thames, Juanita Crook,Pierre Blanchard,Jay Ciezki,Mira Keyes,Gregory Merrick,Charles Catton, Francis Sullivan,Richard Stock,Henry Mok,Jeremy Millar,Brian Moran, Michael Zelefsky,Steven Frank

Brachytherapy（2021）

引用 0|浏览8

暂无评分

摘要

Purpose: Pd-103 has several potential advantages over I-125. Its shorter half-life may preferentially target tissues with lower alpha/beta ratios such as prostate cancer, while its lower energy results in greater dose heterogeneity. We utilized a large multi-institutional and multi-national database to compare clinical and biochemical failures between isotopes.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要